{
  "documentMetadata": {
    "title": "Mastoiditis, Acute",
    "sourceFile": "Mastoiditis, Acute.pdf",
    "lastUpdated": "2024-09-16"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "paragraph",
      "text": "Acute mastoiditis is usually a complication of acute otitis media, much more common in children than adults."
    },
    {
      "type": "list",
      "items": [
        "Antibiotics plus drainage of the middle ear are cornerstones of therapy and sufficient in most cases",
        "Chronic otitis media may include cholesteatoma (keratoma) formation that predisposes to obstruction of ear drainage and predisposes to acute and/or chronic mastoiditis.",
        "Look for suppurative complications: osteomyelitis, suppurative (septic) thrombophlebitis of the lateral venous sinus, epidural or subdural abscess, bacterial meningitis, contiguous brain abscess."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Suggestive clinical findings include tenderness, erythema and swelling over mastoid prominence, protrusion of the ear",
        "Abnormalities (e.g., air cell opacification, bony destruction) on CT or MRI"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "If complication of 1st episode of acute otitis media:",
        "Streptococcus pneumoniae (most common)",
        "Streptococcus pyogenes",
        "Hemophilus influenza",
        "Less common, more likely to be seen in children treated with antibiotics prior to diagnosis of acute mastoiditis",
        "Staphylococcus aureus, including MRSA",
        "Fusobacterium necrophorum",
        "Streptococcus intermedius",
        "Pseudomonas aeruginosa",
        "If secondary to chronic otitis media:",
        "Staphylococcus aureus, including MRSA",
        "Pseudomonas aeruginosa"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "ENT consultation strongly recommended to evaluate need for surgical debridement",
        "Recommendations are for empiric therapy pending culture results",
        "Obtain cultures of auditory canal or middle ear fluid (preferred)",
        "1st episode: medical management, uncomplicated disease (uncommon in adults, suspect complicated disease), no antibiotic treatment prior to diagnosis, pediatric dosing as follows:"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Ampicillin-sulbactam",
            "dose": "200 mg/kg/d",
            "route": "IV",
            "frequency": "in 4 divided doses, max dose 12 gm/day"
          },
          {
            "drug": "Ceftriaxone",
            "dose": "50-100 mg/kg",
            "route": "IV",
            "frequency": "in 2 divided doses, max dose 4 gm/day"
          }
        ]
      }
    },
    {
      "type": "list",
      "items": [
        "Acute exacerbation of chronic otitis media/chronic mastoiditis, prior therapy before diagnosis of mastoiditis, complicated infection (e.g, subperiosteal abscess, osteomyelitis):",
        "ENT surgical consultation/surgical debridement"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "notes": "Child: 60-80 mg/kg IV divided 2-4 times a day to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 µg/mL. Adult: 15-20 mg/kg IV q8-12h to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 µg/mL"
          },
          {
            "drug": "Cefepime",
            "notes": "Child: 150 mg/kg/d IV in 3 divided doses, max dose 2 gm. Adult: 2 gm IV q8h",
            "connector": "+"
          },
          {
            "drug": "Metronidazole",
            "notes": "Child: 22.5 mg/kg/d IV in 3 divided doses, max dose 750 mg. Adult: 750 mg IV q8h",
            "connector": "+"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "1st episode: medical management, uncomplicated disease"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin",
            "notes": "as above"
          },
          {
            "drug": "Linezolid",
            "notes": "(Child: Age < 12 years, 30 mg/kg/d in 3 divided doses, max dose 600 mg per dose; Age > 12 years, 10 mg/kg q12h, max dose 600 mg per dose; Adult: 600 mg IV/po q12h)",
            "connector": "or"
          },
          {
            "drug": "Piperacillin-tazobactam",
            "notes": "Child: 300 mg/kg/d of piperacillin component in 4 divided doses, max dose 16 gm/d. Adult: 4.5 gm IV q6h",
            "connector": "+"
          }
        ]
      }
    },
    {
      "type": "list",
      "items": [
        "Acute exacerbation of chronic otitis media/chronic mastoiditis, complicated infection (e.g, subperiosteal abscess, osteomyelitis), severe beta-lactam allergy",
        "ENT surgical consultation/surgical debridement"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Vancomycin or Linezolid",
            "notes": "as above"
          },
          {
            "drug": "Aztreonam",
            "notes": "(Child: 30 mg/kg IV q6h; Adult: 2 gm IV q6h)",
            "connector": "+"
          },
          {
            "drug": "Metronidazole",
            "notes": "(Child: 22.5 mg/kg/d IV in 3 divided doses, max dose 750 mg; Adult 750 mg IV q8h)",
            "connector": "+"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Duration of therapy",
        "Guided by severity of disease, longer courses for more complicated disease",
        "7-10 days IV, then transition to oral therapy based on results of culture and susceptibility data to complete a 4-week course",
        "Consider a longer course of therapy for more severe or complicated disease",
        "De-escalate, modify regimen based on results of culture and susceptibility data",
        "No need to include MRSA coverage if the PCR nasal swab is negative for MRSA"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Unusual causes of mastoiditis, which is usually chronic include: Nocardia spp., Mycobacterium tuberculosis, Actinomyces.",
        "Reviews: Pediatr Rev. 2018; 39:267, J Laryngol Otol. 2018; 132:96, Int J Pediatr Otorhinolaryngol. 2019;125:187."
      ]
    }
  ]
}
